Page last updated: 2024-10-26

valproic acid and Lymphoma, Follicular

valproic acid has been researched along with Lymphoma, Follicular in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Lymphoma, Follicular: Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.

Research Excerpts

ExcerptRelevanceReference
"Patients with platinum-resistant ovarian cancer (PROC) have limited therapeutic options and poor survival."3.11Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer. ( Barathi, D; Dahagama, S; Dubashi, B; Ganesan, P; Goenka, L; Kayal, S; Krishnamoorthy, N; Mathaiyan, J; Nakka, T; Thumaty, DB, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nakka, T1
Goenka, L1
Dubashi, B1
Kayal, S1
Mathaiyan, J1
Barathi, D1
Krishnamoorthy, N1
Thumaty, DB1
Dahagama, S1
Ganesan, P1

Trials

1 trial available for valproic acid and Lymphoma, Follicular

ArticleYear
Phase II study of sodium valproate in combination with oral etoposide in platinum-resistant ovarian cancer.
    Medical oncology (Northwood, London, England), 2022, Sep-29, Volume: 39, Issue:12

    Topics: Carcinoma, Ovarian Epithelial; Communicable Disease Control; COVID-19; Cytotoxins; Etoposide; Female

2022